Oral laquinimod treatment in multiple sclerosis
Introduction: Multiple sclerosis (MS) is a chronic disease of the central nervous system, probably of autoimmune origin. Its early treatment with interferon beta or glatiramer acetate reduces the number of exacerbations, slows disability progression and improves the quality of life, but these treatm...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier España
2011-01-01
|
| Edice: | Neurología (English Edition) |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2173580811700220 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|